Botulinum toxin treatment in patients with facial synkinesis.
Laskawi
R
R
ENT-Department, University of Göttingen, Germany.
Damenz
W
W
Roggenkämper
P
P
Baetz
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage*; D001905:Botulinum Toxins / Q000008:administration & dosage*; D020820:Dyskinesias / Q000150:complications / Q000188:drug therapy*; D005141:Eyelid Diseases / Q000150:complications / Q000188:drug therapy*; D005158:Facial Paralysis / Q000150:complications*; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins